ArticleBone marrow transplantation2021

Increased donor inhibitory KIR with known HLA interactions provide protection from relapse following HLA matched unrelated donor HCT for AML.

Elizabeth Krieger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.